The Lake Forest -
based generic drugmaker alleges in a suit that the German medical equipment giant used a false pretext to walk away from their acquisition agreement.
Akorn shares plummeted Monday after Germany's Fresenius Medical ditched its planned $ 5 billion takeover amid allegations of data misconduct at the Lake Forest, Ill. -
based generic drugmaker.
• Fresenius SE & Co KGaA (DB: FRE) is close to acquiring Akorn (Nasdaq: AKRX), a Lake Forest, Ill. -
based generic drugmaker, in an all - cash deal valuing the company at more than $ 4 billion, according to Reuters.
Not exact matches
Teva Pharmaceuticals has proposed buying rival Mylan for $ 40 billion in cash and stock, as the Israel -
based drugmaker looks to gain dominance among
generic pharmaceutical companies.
This New Jersey -
based drugmaker posted a relatively flat year - over-year earnings comparison, which can be attributed to increases in
generic competition in several key franchises, which was partially offset by ongoing cost - control initiatives.